{"transactions":[{"id":4622269,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-09-17T23:29:28.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":864,"price":9.129,"value":7887.456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":1438495,"source":{"system":"sec-edgar","filing":"0001193125-26-394738","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526394738/ownership.xml","form_type":"4"}},{"id":788578,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T20:30:09.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":265000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest monthly following May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":265000,"derivative":{"exercise_price":33.93,"expiration_date":"2036-05-04","underlying":"Common Stock","underlying_shares":265000},"source":{"system":"sec-edgar","filing":"0001193125-26-212114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526212114/ownership.xml","form_type":"4"}},{"id":788577,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-07T20:30:09.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":79000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on May 5, 2026. 1/4 of the total number of RSUs granted vest on each of the first four anniversaries of May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes RSUs."}],"balance_after":1437631,"source":{"system":"sec-edgar","filing":"0001193125-26-212114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526212114/ownership.xml","form_type":"4"}},{"id":838282,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-17T20:54:28.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":1463,"price":9.129,"value":13355.727,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":1358631,"source":{"system":"sec-edgar","filing":"0001193125-26-111083","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526111083/ownership.xml","form_type":"4"}},{"id":1072374,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-07T20:36:24.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":570000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following August 7, 2025, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":570000,"derivative":{"exercise_price":10.75,"expiration_date":"2035-08-06","underlying":"Common Stock","underlying_shares":570000},"source":{"system":"sec-edgar","filing":"0000950170-25-105128","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017025105128/ownership.xml","form_type":"4"}},{"id":1200303,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-18T22:44:12.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":1241,"price":9.775,"value":12130.775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":1357168,"source":{"system":"sec-edgar","filing":"0000950170-25-041551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017025041551/ownership.xml","form_type":"4"}},{"id":1383021,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-22T21:13:41.000Z","date":"2024-10-21","kind":"sale","planned":true,"acquired":false,"shares":13188,"price":28.1597,"value":371370.1236,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $27.8957 to $28.5951. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1355927,"source":{"system":"sec-edgar","filing":"0000950170-24-116345","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024116345/ownership.xml","form_type":"4"}},{"id":1383020,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-22T21:13:41.000Z","date":"2024-10-21","kind":"sale","planned":true,"acquired":false,"shares":5896,"price":27.3204,"value":161081.0784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.89 to $27.84. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1369115,"source":{"system":"sec-edgar","filing":"0000950170-24-116345","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024116345/ownership.xml","form_type":"4"}},{"id":1383019,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-22T21:13:41.000Z","date":"2024-10-18","kind":"sale","planned":true,"acquired":false,"shares":43636,"price":27.0143,"value":1178795.9948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.60 to $27.51. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1375011,"source":{"system":"sec-edgar","filing":"0000950170-24-116345","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024116345/ownership.xml","form_type":"4"}},{"id":1384918,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-18T00:12:40.000Z","date":"2024-10-17","kind":"sale","planned":true,"acquired":false,"shares":200,"price":26.37,"value":5274.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."}],"balance_after":1418647,"source":{"system":"sec-edgar","filing":"0000950170-24-115432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024115432/ownership.xml","form_type":"4"}},{"id":1384917,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-18T00:12:40.000Z","date":"2024-10-17","kind":"sale","planned":true,"acquired":false,"shares":15194,"price":25.839,"value":392597.766,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $25.30 to $26.16. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1418847,"source":{"system":"sec-edgar","filing":"0000950170-24-115432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024115432/ownership.xml","form_type":"4"}},{"id":1384916,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-18T00:12:40.000Z","date":"2024-10-16","kind":"sale","planned":true,"acquired":false,"shares":3922,"price":26.9789,"value":105811.2458,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.79 to $27.08. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1434041,"source":{"system":"sec-edgar","filing":"0000950170-24-115432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024115432/ownership.xml","form_type":"4"}},{"id":1384915,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-18T00:12:40.000Z","date":"2024-10-16","kind":"sale","planned":true,"acquired":false,"shares":24475,"price":26.2334,"value":642062.465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $25.78 to $26.78. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1437963,"source":{"system":"sec-edgar","filing":"0000950170-24-115432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024115432/ownership.xml","form_type":"4"}},{"id":1384914,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-18T00:12:40.000Z","date":"2024-10-16","kind":"sale","planned":true,"acquired":false,"shares":4900,"price":25.2155,"value":123555.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.72 to $25.59. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1462438,"source":{"system":"sec-edgar","filing":"0000950170-24-115432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024115432/ownership.xml","form_type":"4"}},{"id":1384913,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-18T00:12:40.000Z","date":"2024-10-15","kind":"sale","planned":true,"acquired":false,"shares":10035,"price":24.3119,"value":243969.9165,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.8667. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1467338,"source":{"system":"sec-edgar","filing":"0000950170-24-115432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024115432/ownership.xml","form_type":"4"}},{"id":1394728,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-02T21:38:38.000Z","date":"2024-09-30","kind":"sale","planned":true,"acquired":false,"shares":500,"price":24,"value":12000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."}],"balance_after":1477373,"source":{"system":"sec-edgar","filing":"0000950170-24-111702","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024111702/ownership.xml","form_type":"4"}},{"id":1399529,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-25T22:44:20.000Z","date":"2024-09-25","kind":"sale","planned":true,"acquired":false,"shares":600,"price":24.01,"value":14406.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.06. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1477873,"source":{"system":"sec-edgar","filing":"0000950170-24-109410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024109410/ownership.xml","form_type":"4"}},{"id":1399528,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-25T22:44:20.000Z","date":"2024-09-24","kind":"sale","planned":true,"acquired":false,"shares":1055,"price":24.0196,"value":25340.678,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1478473,"source":{"system":"sec-edgar","filing":"0000950170-24-109410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024109410/ownership.xml","form_type":"4"}},{"id":1399527,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-25T22:44:20.000Z","date":"2024-09-23","kind":"sale","planned":true,"acquired":false,"shares":10092,"price":24.1257,"value":243476.5644,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.005 to $24.25. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1479528,"source":{"system":"sec-edgar","filing":"0000950170-24-109410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024109410/ownership.xml","form_type":"4"}},{"id":1401682,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-20T22:24:52.000Z","date":"2024-09-20","kind":"sale","planned":true,"acquired":false,"shares":7109,"price":24.1877,"value":171950.3593,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.8963. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1489620,"source":{"system":"sec-edgar","filing":"0000950170-24-108533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024108533/ownership.xml","form_type":"4"}},{"id":1401681,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-20T22:24:52.000Z","date":"2024-09-19","kind":"sale","planned":true,"acquired":false,"shares":27,"price":25.0969,"value":677.6163,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."}],"balance_after":1496729,"source":{"system":"sec-edgar","filing":"0000950170-24-108533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024108533/ownership.xml","form_type":"4"}},{"id":1401680,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-20T22:24:52.000Z","date":"2024-09-19","kind":"sale","planned":true,"acquired":false,"shares":5671,"price":24.3014,"value":137813.2394,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $24.00 to $24.9749. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1496756,"source":{"system":"sec-edgar","filing":"0000950170-24-108533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024108533/ownership.xml","form_type":"4"}},{"id":1401679,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-20T22:24:52.000Z","date":"2024-09-18","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":24,"value":84000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."}],"balance_after":1502427,"source":{"system":"sec-edgar","filing":"0000950170-24-108533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024108533/ownership.xml","form_type":"4"}},{"id":1405350,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-17T21:15:27.000Z","date":"2024-09-13","kind":"grant","planned":false,"acquired":true,"shares":1350,"price":6.579,"value":8881.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":1505927,"source":{"system":"sec-edgar","filing":"0000950170-24-107399","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024107399/ownership.xml","form_type":"4"}},{"id":1431491,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-16T21:50:57.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":390000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following August 14, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":390000,"derivative":{"exercise_price":21.57,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":390000},"source":{"system":"sec-edgar","filing":"0000950170-24-098175","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024098175/ownership.xml","form_type":"4"}},{"id":1569355,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-03-19T23:38:59.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":1880,"price":6.579,"value":12368.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":1504577,"source":{"system":"sec-edgar","filing":"0000950170-24-033814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024033814/ownership.xml","form_type":"4"}},{"id":1656966,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-07T01:22:06.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":13817,"price":16.9668,"value":234430.2756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.51 to $17.32. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1502697,"source":{"system":"sec-edgar","filing":"0000950170-24-011879","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024011879/ownership.xml","form_type":"4"}},{"id":1656965,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-07T01:22:06.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":7187,"price":17.0439,"value":122494.5093,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.16. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1516514,"source":{"system":"sec-edgar","filing":"0000950170-24-011879","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024011879/ownership.xml","form_type":"4"}},{"id":1656964,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-07T01:22:06.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":78996,"price":16.4459,"value":1299160.3164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.9995. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1523701,"source":{"system":"sec-edgar","filing":"0000950170-24-011879","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024011879/ownership.xml","form_type":"4"}},{"id":1777552,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-19T23:36:09.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":1421,"price":6.579,"value":9348.759,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":1602697,"source":{"system":"sec-edgar","filing":"0001209191-23-050092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123050092/doc4.xml","form_type":"4"}},{"id":1819381,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-01T21:38:34.000Z","date":"2023-07-28","kind":"grant","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":330000,"derivative":{"exercise_price":14.35,"expiration_date":"2033-07-27","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001209191-23-044044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123044044/doc4.xml","form_type":"4"}},{"id":1844372,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-26T23:30:06.000Z","date":"2023-06-23","kind":"sale","planned":true,"acquired":false,"shares":6481,"price":17.5071,"value":113463.5151,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $17.41 to $17.75. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1601276,"source":{"system":"sec-edgar","filing":"0001209191-23-039807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123039807/doc4.xml","form_type":"4"}},{"id":1844371,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-26T23:30:06.000Z","date":"2023-06-23","kind":"sale","planned":true,"acquired":false,"shares":14231,"price":16.7801,"value":238797.6031,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $16.335 to $17.195. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1607757,"source":{"system":"sec-edgar","filing":"0001209191-23-039807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123039807/doc4.xml","form_type":"4"}},{"id":1844370,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-26T23:30:06.000Z","date":"2023-06-22","kind":"sale","planned":true,"acquired":false,"shares":500,"price":17.386,"value":8693.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $17.35 to $17.42. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1621988,"source":{"system":"sec-edgar","filing":"0001209191-23-039807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123039807/doc4.xml","form_type":"4"}},{"id":1844369,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-26T23:30:06.000Z","date":"2023-06-22","kind":"sale","planned":true,"acquired":false,"shares":2978,"price":16.9772,"value":50558.1016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $16.29 to $17.29. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1622488,"source":{"system":"sec-edgar","filing":"0001209191-23-039807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123039807/doc4.xml","form_type":"4"}},{"id":1848012,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-22T00:16:55.000Z","date":"2023-06-21","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":18.1809,"value":19998.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $18.11 to $18.395. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1625466,"source":{"system":"sec-edgar","filing":"0001209191-23-038945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123038945/doc4.xml","form_type":"4"}},{"id":1848011,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-22T00:16:55.000Z","date":"2023-06-21","kind":"sale","planned":true,"acquired":false,"shares":14027,"price":17.7057,"value":248357.8539,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $17.075 to $18.035. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1626566,"source":{"system":"sec-edgar","filing":"0001209191-23-038945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123038945/doc4.xml","form_type":"4"}},{"id":1848010,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-22T00:16:55.000Z","date":"2023-06-21","kind":"sale","planned":true,"acquired":false,"shares":4629,"price":16.119,"value":74614.851,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $16.00 to $16.905. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1640593,"source":{"system":"sec-edgar","filing":"0001209191-23-038945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123038945/doc4.xml","form_type":"4"}},{"id":1848009,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-22T00:16:55.000Z","date":"2023-06-20","kind":"sale","planned":true,"acquired":false,"shares":1300,"price":16.5333,"value":21493.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $16.04 to $16.82. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1645222,"source":{"system":"sec-edgar","filing":"0001209191-23-038945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123038945/doc4.xml","form_type":"4"}},{"id":1848008,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-22T00:16:55.000Z","date":"2023-06-16","kind":"sale","planned":true,"acquired":false,"shares":600,"price":18.5,"value":11100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $18.00 to $19.00. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1646522,"source":{"system":"sec-edgar","filing":"0001209191-23-038945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123038945/doc4.xml","form_type":"4"}},{"id":1848007,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-22T00:16:55.000Z","date":"2023-06-16","kind":"sale","planned":true,"acquired":false,"shares":50838,"price":17.06,"value":867296.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $17.00 to $17.98. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1647122,"source":{"system":"sec-edgar","filing":"0001209191-23-038945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123038945/doc4.xml","form_type":"4"}},{"id":1848006,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-22T00:16:55.000Z","date":"2023-06-16","kind":"sale","planned":true,"acquired":false,"shares":3316,"price":16.49,"value":54680.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $16.00 to $16.97. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1697960,"source":{"system":"sec-edgar","filing":"0001209191-23-038945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123038945/doc4.xml","form_type":"4"}},{"id":1854645,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T01:00:29.000Z","date":"2023-06-15","kind":"exercise","planned":true,"acquired":false,"shares":12773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":376837,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":12773},"source":{"system":"sec-edgar","filing":"0001209191-23-037613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037613/doc4.xml","form_type":"4"}},{"id":1854644,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T01:00:29.000Z","date":"2023-06-13","kind":"exercise","planned":true,"acquired":false,"shares":7927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":389610,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":7927},"source":{"system":"sec-edgar","filing":"0001209191-23-037613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037613/doc4.xml","form_type":"4"}},{"id":1854643,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-16T01:00:29.000Z","date":"2023-06-15","kind":"sale","planned":true,"acquired":false,"shares":12773,"price":16.1275,"value":205996.5575,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.60. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-037613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037613/doc4.xml","form_type":"4"}},{"id":1854642,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-16T01:00:29.000Z","date":"2023-06-15","kind":"exercise","planned":true,"acquired":true,"shares":12773,"price":2.25,"value":28739.25,"ownership":{"direct":true},"balance_after":1714049,"source":{"system":"sec-edgar","filing":"0001209191-23-037613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037613/doc4.xml","form_type":"4"}},{"id":1854641,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-16T01:00:29.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":7927,"price":16.0048,"value":126870.0496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-037613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037613/doc4.xml","form_type":"4"}},{"id":1854640,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-16T01:00:29.000Z","date":"2023-06-13","kind":"exercise","planned":true,"acquired":true,"shares":7927,"price":2.25,"value":17835.75,"ownership":{"direct":true},"balance_after":1709203,"source":{"system":"sec-edgar","filing":"0001209191-23-037613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123037613/doc4.xml","form_type":"4"}},{"id":1925361,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-05T21:20:03.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":397537,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-23-023402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123023402/doc4.xml","form_type":"4"}},{"id":1925360,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-05T21:20:03.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":16.126,"value":32252.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 and $16.240. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-023402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123023402/doc4.xml","form_type":"4"}},{"id":1925359,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-05T21:20:03.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":2.25,"value":4500.0,"ownership":{"direct":true},"balance_after":1703276,"source":{"system":"sec-edgar","filing":"0001209191-23-023402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123023402/doc4.xml","form_type":"4"}},{"id":1934115,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T23:02:07.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":399537,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-23-021947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021947/doc4.xml","form_type":"4"}},{"id":1934114,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T23:02:07.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":false,"shares":2407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":400037,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":2407},"source":{"system":"sec-edgar","filing":"0001209191-23-021947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021947/doc4.xml","form_type":"4"}},{"id":1934113,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T23:02:07.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":false,"shares":1420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":402444,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":1420},"source":{"system":"sec-edgar","filing":"0001209191-23-021947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021947/doc4.xml","form_type":"4"}},{"id":1934112,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-31T23:02:07.000Z","date":"2023-03-31","kind":"sale","planned":false,"acquired":false,"shares":500,"price":16.046,"value":8023.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-021947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021947/doc4.xml","form_type":"4"}},{"id":1934111,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-31T23:02:07.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":2.25,"value":1125.0,"ownership":{"direct":true},"balance_after":1701776,"source":{"system":"sec-edgar","filing":"0001209191-23-021947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021947/doc4.xml","form_type":"4"}},{"id":1934110,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-31T23:02:07.000Z","date":"2023-03-30","kind":"sale","planned":false,"acquired":false,"shares":2407,"price":16.0166,"value":38551.9562,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-021947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021947/doc4.xml","form_type":"4"}},{"id":1934109,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-31T23:02:07.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":true,"shares":2407,"price":2.25,"value":5415.75,"ownership":{"direct":true},"balance_after":1703683,"source":{"system":"sec-edgar","filing":"0001209191-23-021947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021947/doc4.xml","form_type":"4"}},{"id":1934108,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-31T23:02:07.000Z","date":"2023-03-29","kind":"sale","planned":false,"acquired":false,"shares":1420,"price":16.1835,"value":22980.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-021947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021947/doc4.xml","form_type":"4"}},{"id":1934107,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-31T23:02:07.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":true,"shares":1420,"price":2.25,"value":3195.0,"ownership":{"direct":true},"balance_after":1702696,"source":{"system":"sec-edgar","filing":"0001209191-23-021947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021947/doc4.xml","form_type":"4"}},{"id":1936987,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-28T23:09:04.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":2779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":403864,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":2779},"source":{"system":"sec-edgar","filing":"0001209191-23-021443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021443/doc4.xml","form_type":"4"}},{"id":1936986,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-28T23:09:04.000Z","date":"2023-03-27","kind":"exercise","planned":false,"acquired":false,"shares":2963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":406643,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":2963},"source":{"system":"sec-edgar","filing":"0001209191-23-021443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021443/doc4.xml","form_type":"4"}},{"id":1936985,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-28T23:09:04.000Z","date":"2023-03-24","kind":"exercise","planned":false,"acquired":false,"shares":170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":409606,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":170},"source":{"system":"sec-edgar","filing":"0001209191-23-021443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021443/doc4.xml","form_type":"4"}},{"id":1936984,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-28T23:09:04.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":2779,"price":16,"value":44464.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-021443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021443/doc4.xml","form_type":"4"}},{"id":1936983,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-28T23:09:04.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":2779,"price":2.25,"value":6252.75,"ownership":{"direct":true},"balance_after":1704055,"source":{"system":"sec-edgar","filing":"0001209191-23-021443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021443/doc4.xml","form_type":"4"}},{"id":1936982,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-28T23:09:04.000Z","date":"2023-03-27","kind":"sale","planned":false,"acquired":false,"shares":2963,"price":16,"value":47408.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-021443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021443/doc4.xml","form_type":"4"}},{"id":1936981,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-28T23:09:04.000Z","date":"2023-03-27","kind":"exercise","planned":false,"acquired":true,"shares":2963,"price":2.25,"value":6666.75,"ownership":{"direct":true},"balance_after":1704239,"source":{"system":"sec-edgar","filing":"0001209191-23-021443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021443/doc4.xml","form_type":"4"}},{"id":1936980,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-28T23:09:04.000Z","date":"2023-03-24","kind":"sale","planned":false,"acquired":false,"shares":170,"price":16,"value":2720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-021443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021443/doc4.xml","form_type":"4"}},{"id":1936979,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-28T23:09:04.000Z","date":"2023-03-24","kind":"exercise","planned":false,"acquired":true,"shares":170,"price":2.25,"value":382.5,"ownership":{"direct":true},"balance_after":1701446,"source":{"system":"sec-edgar","filing":"0001209191-23-021443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123021443/doc4.xml","form_type":"4"}},{"id":1940341,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-23T23:49:09.000Z","date":"2023-03-23","kind":"exercise","planned":false,"acquired":false,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":409776,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":2800},"source":{"system":"sec-edgar","filing":"0001209191-23-020848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123020848/doc4.xml","form_type":"4"}},{"id":1940340,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-23T23:49:09.000Z","date":"2023-03-22","kind":"exercise","planned":false,"acquired":false,"shares":4043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":412576,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":4043},"source":{"system":"sec-edgar","filing":"0001209191-23-020848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123020848/doc4.xml","form_type":"4"}},{"id":1940339,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-23T23:49:09.000Z","date":"2023-03-21","kind":"exercise","planned":false,"acquired":false,"shares":12393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date."}],"balance_after":416619,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":12393},"source":{"system":"sec-edgar","filing":"0001209191-23-020848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123020848/doc4.xml","form_type":"4"}},{"id":1940338,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:49:09.000Z","date":"2023-03-23","kind":"sale","planned":false,"acquired":false,"shares":2800,"price":16,"value":44800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-020848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123020848/doc4.xml","form_type":"4"}},{"id":1940337,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:49:09.000Z","date":"2023-03-23","kind":"exercise","planned":false,"acquired":true,"shares":2800,"price":2.25,"value":6300.0,"ownership":{"direct":true},"balance_after":1704076,"source":{"system":"sec-edgar","filing":"0001209191-23-020848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123020848/doc4.xml","form_type":"4"}},{"id":1940336,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:49:09.000Z","date":"2023-03-22","kind":"sale","planned":false,"acquired":false,"shares":4043,"price":16,"value":64688.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-020848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123020848/doc4.xml","form_type":"4"}},{"id":1940335,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:49:09.000Z","date":"2023-03-22","kind":"exercise","planned":false,"acquired":true,"shares":4043,"price":2.25,"value":9096.75,"ownership":{"direct":true},"balance_after":1705319,"source":{"system":"sec-edgar","filing":"0001209191-23-020848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123020848/doc4.xml","form_type":"4"}},{"id":1940334,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:49:09.000Z","date":"2023-03-21","kind":"sale","planned":false,"acquired":false,"shares":12393,"price":16,"value":198288.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-020848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123020848/doc4.xml","form_type":"4"}},{"id":1940333,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:49:09.000Z","date":"2023-03-21","kind":"exercise","planned":false,"acquired":true,"shares":12393,"price":2.25,"value":27884.25,"ownership":{"direct":true},"balance_after":1713669,"source":{"system":"sec-edgar","filing":"0001209191-23-020848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123020848/doc4.xml","form_type":"4"}},{"id":1947463,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-17T21:28:32.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":1808,"price":6.579,"value":11894.832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":1701276,"source":{"system":"sec-edgar","filing":"0001209191-23-019793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123019793/doc4.xml","form_type":"4"}},{"id":2163249,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-08T21:37:32.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":270000,"derivative":{"exercise_price":7.14,"expiration_date":"2032-09-05","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001209191-22-049213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122049213/doc4.xml","form_type":"4"}},{"id":2163248,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-08T21:37:32.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":3125,"price":8.5255,"value":26642.1875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":1699468,"source":{"system":"sec-edgar","filing":"0001209191-22-049213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122049213/doc4.xml","form_type":"4"}},{"id":2524764,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T23:39:40.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":25884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests based on achievement of a performance objective."}],"balance_after":25884,"derivative":{"exercise_price":24.15,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":25884},"source":{"system":"sec-edgar","filing":"0001209191-21-063010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919121063010/doc4.xml","form_type":"4"}},{"id":2524763,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T23:39:40.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":25884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests based on achievement of a performance objective."}],"balance_after":25884,"derivative":{"exercise_price":24.15,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":25884},"source":{"system":"sec-edgar","filing":"0001209191-21-063010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919121063010/doc4.xml","form_type":"4"}},{"id":2524762,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T23:39:40.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":215038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following November 2, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":215038,"derivative":{"exercise_price":24.15,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":215038},"source":{"system":"sec-edgar","filing":"0001209191-21-063010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919121063010/doc4.xml","form_type":"4"}},{"id":2566267,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2021-09-17T20:43:39.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":13093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":34007},"source":{"system":"sec-edgar","filing":"0000899243-21-036426","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089924321036426/doc4.xml","form_type":"4"}},{"id":2566266,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-17T20:43:39.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":34007,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."}],"balance_after":1696343,"source":{"system":"sec-edgar","filing":"0000899243-21-036426","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089924321036426/doc4.xml","form_type":"4"}},{"id":3504733,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2019-06-03T19:29:07.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.22,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-19-003239","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218019003239/primarydocument.xml","form_type":"4"}},{"id":3949787,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-05-02T19:54:35.000Z","date":"2018-04-30","kind":"sale","acquired":false,"shares":100,"price":20,"value":2000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."}],"balance_after":570991,"source":{"system":"sec-edgar","filing":"0001562180-18-002144","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218018002144/primarydocument.xml","form_type":"4"}},{"id":3957208,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-04-25T19:21:15.000Z","date":"2018-04-25","kind":"sale","acquired":false,"shares":300,"price":20,"value":6000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."}],"balance_after":571091,"source":{"system":"sec-edgar","filing":"0001562180-18-001976","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218018001976/primarydocument.xml","form_type":"4"}},{"id":3957207,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-04-25T19:21:15.000Z","date":"2018-04-24","kind":"sale","acquired":false,"shares":150,"price":20,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."}],"balance_after":571391,"source":{"system":"sec-edgar","filing":"0001562180-18-001976","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218018001976/primarydocument.xml","form_type":"4"}},{"id":3957206,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-04-25T19:21:15.000Z","date":"2018-04-23","kind":"sale","acquired":false,"shares":525,"price":20,"value":10500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."}],"balance_after":571541,"source":{"system":"sec-edgar","filing":"0001562180-18-001976","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218018001976/primarydocument.xml","form_type":"4"}},{"id":3960091,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-04-19T18:00:51.000Z","date":"2018-04-18","kind":"sale","acquired":false,"shares":15810,"price":20.0885,"value":317599.185,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $20.00 to $20.64, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":572066,"source":{"system":"sec-edgar","filing":"0001140361-18-019087","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000114036118019087/doc1.xml","form_type":"4"}},{"id":3960090,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-04-19T18:00:51.000Z","date":"2018-04-17","kind":"sale","acquired":false,"shares":2201,"price":20,"value":44020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."}],"balance_after":587876,"source":{"system":"sec-edgar","filing":"0001140361-18-019087","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000114036118019087/doc1.xml","form_type":"4"}},{"id":3964780,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-04-12T18:45:17.000Z","date":"2018-04-10","kind":"sale","acquired":false,"shares":3779,"price":20.0161,"value":75640.8419,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $20.00 to $20.22, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":590077,"source":{"system":"sec-edgar","filing":"0001140361-18-018411","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000114036118018411/doc1.xml","form_type":"4"}},{"id":3966981,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-04-09T19:18:14.000Z","date":"2018-04-09","kind":"sale","acquired":false,"shares":2824,"price":20,"value":56480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."}],"balance_after":593856,"source":{"system":"sec-edgar","filing":"0001140361-18-017877","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000114036118017877/doc1.xml","form_type":"4"}},{"id":3966980,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-04-09T19:18:14.000Z","date":"2018-04-05","kind":"sale","acquired":false,"shares":5386,"price":20.001,"value":107725.386,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $20.00 to $20.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":596680,"source":{"system":"sec-edgar","filing":"0001140361-18-017877","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000114036118017877/doc1.xml","form_type":"4"}},{"id":3987684,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-03-20T19:00:14.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":5876,"price":20,"value":117520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."}],"balance_after":602066,"source":{"system":"sec-edgar","filing":"0001140361-18-014357","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000114036118014357/doc1.xml","form_type":"4"}},{"id":3996403,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-03-14T19:13:14.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":3452,"price":20.1127,"value":69429.0404,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $20.00 to $20.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":607942,"source":{"system":"sec-edgar","filing":"0001140361-18-013486","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000114036118013486/doc1.xml","form_type":"4"}},{"id":4003474,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-03-09T19:00:15.000Z","date":"2018-03-09","kind":"sale","acquired":false,"shares":2438,"price":20.0099,"value":48784.1362,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $20.00 to $20.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":611394,"source":{"system":"sec-edgar","filing":"0001140361-18-012906","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000114036118012906/doc1.xml","form_type":"4"}},{"id":4003473,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":49127,"kind":"person","name":"Harris Todd","position":1,"cik":"0001711463","reported_name":"Harris Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2018-03-09T19:00:15.000Z","date":"2018-03-08","kind":"sale","acquired":false,"shares":14530,"price":20.0342,"value":291096.926,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $20.00 to $20.28, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":613832,"source":{"system":"sec-edgar","filing":"0001140361-18-012906","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000114036118012906/doc1.xml","form_type":"4"}}],"next_cursor":"2018-03-09T19:00:15.000000Z,4003473"}